• Fri, March 3, 2023
Andrew Fein Reiterated (SYRS) at Strong Buy and Held Target at $15 on, Mar 3rd, 2023
Andrew Fein of HC Wainwright & Co., Reiterated "Syros Pharmaceuticals, Inc." (SYRS) at Strong Buy and Held Target at $15 on, Mar 3rd, 2023.
Andrew has made no other calls on SYRS in the last 4 months.
There are 2 other peers that have a rating on SYRS. Out of the 2 peers that are also analyzing SYRS, 0 agree with Andrew's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Andrew
- Edward Tenthoff of "Piper Sandler" Maintained at Buy with Decreased Target to $20 on, Thursday, January 5th, 2023
- Jason Butler of "JMP Securities" Maintained at Buy with Decreased Target to $16 on, Tuesday, November 15th, 2022
